Effects of Agomelatine on Sleep Across Populations: A Systematic Review and Meta‐Analysis
Journal of Sleep Research · 2026-06 · 35 (3)
DOI: 10.1111/jsr.70231 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Sleep Research, online erschienen am 02.11.2025. Verfasst von Anastasios Stefanou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Psychiatry, Department of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Acetamides, Hypnotics and Sedatives, Sleep, Sleep Quality. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Agomelatine, a melatoninergic antidepressant, is often prescribed to improve sleep disturbance, though meta‐analytic evidence is currently lacking. This systematic review and meta‐analysis assessed its efficacy and tolerability in sleep outcomes compared to placebo. We systematically searched clinical trial registries (Cochrane Central, WHO ICTRP, ClinicalTrials.gov) and databases (MEDLINE, Embase, APA PsycINFO) up to February 16, 2025, for Randomised Controlled Trials (RCTs) comparing agomelatine with placebo that reported sleep‐related outcomes. Analyses were conducted using a random‐effects model on an intention‐to‐treat basis. Risk ratios (RR) were used for dichotomous outcomes, weighted mean differences (WMD) for continuous outcomes, and Hedge's adjusted g (SMD) when different scales were used. Primary outcomes included subjective and objective total sleep time, subjective sleep quality, and treatment‐emergent somnolence and insomnia. Subgroup and sensitivity analyses explored heterogeneity and assessed robustness. Twenty‐five RCTs with 6812 participants were included. No significant effect was found for objective total sleep time (MD = −15.73 min, 95% CI: −49.68; 18.22), while subjective sleep quality improved more with agomelatine than placebo (SMD = 0.31, 95% CI: 0.21; 0.40). Agomelatine was associated with fewer incidents of insomnia (RR = 0.59, 95% CI: 0.39; 0.90) but more incidents of somnolence (RR = 1.34, 95% CI: 1.02; 1.75). Agomelatine was found to cause marginally more adverse effects than placebo (RR = 1.05, 95% CI: 1.00; 1.11). Overall, agomelatine appears to slightly improve sleep quality and is well‐tolerated and safe, although the limited data for many outcomes warrant cautious interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Psychiatry, Department of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Medical School, University of Thessaly, Larisa, Greece.
- Centre for Trials Research, Cardiff University, Cardiff, UK.
- Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.
- Department of Psychiatry, School of Medicine, University of Thessaly, Larissa, Greece.
- Department of Geriatric Psychiatry, Aneurin Bevan University Health Board, Newport, UK.
ORCID-Profile: Anastasios Stefanou, Panagiota Fallon, Eleni Glarou
Zitieren
APA
Stefanou, A., Anastasiou, I., Fallon, P., Glarou, E., Christodoulou, N., Lappas, A. S., Bozikas, V. P., & Samara, M. T. (2026). Effects of Agomelatine on Sleep Across Populations: A Systematic Review and Meta‐Analysis. Journal of Sleep Research, 35(3). https://doi.org/10.1111/jsr.70231
Vancouver
Stefanou A, Anastasiou I, Fallon P, Glarou E, Christodoulou N, Lappas AS, et al. Effects of Agomelatine on Sleep Across Populations: A Systematic Review and Meta‐Analysis. Journal of Sleep Research. 2026;35(3). doi:10.1111/jsr.70231
BibTeX
@article{Stefanou2026,
author = {Stefanou, Anastasios and Anastasiou, Ioannis and Fallon, Panagiota and Glarou, Eleni and Christodoulou, Nikolaos and Lappas, Andreas S and Bozikas, Vasilios-Panteleimon and Samara, Myrto T},
title = {Effects of Agomelatine on Sleep Across Populations: A Systematic Review and Meta‐Analysis},
journal = {Journal of Sleep Research},
year = {2026},
volume = {35},
number = {3},
doi = {10.1111/jsr.70231}
}
EUVIMED